Sucampo Announces Pricing of $260.0 Million 3.25% Convertible Senior Notes due 2021 Pharmaceutical Investing
Allergan to Acquire Acelity L.P. Inc.'s LifeCell Corporation for $2.9 Billion Pharmaceutical Investing
MediWound Granted US Patent for MWPC003 for the Treatment of Connective Tissue Diseases Pharmaceutical Investing
Factor Therapeutics Announces Commencement of Phase II Trial of a Novel Topical Biologic for the Treatment of Chronic Wounds Life Science Investing
Cellectar Biosciences Announces US and Japanese Patent Allowances for Diagnostic and Optical Imaging PDCs Pharmaceutical Investing
Loxo Oncology Outlines Plans for Accelerated Path to US FDA Approval for Larotrectinib Biotech Investing
Cellceutix Reports 24 Core Phase 2b Clinical Trial Sites for Oral Prurisol Treatment of Moderate-To-Severe Psoriasis Pharmaceutical Investing
Spring Bank and Arbutus Biopharma Announce Preclinical Collaboration in Study of Chronic Hepatitis B Pharmaceutical Investing
